Skip to main content
ORKA logo

ORKA · Oruka Therapeutics, Inc. · Analyst Estimates

Track ORKA — free
$81.25 +3.97 (+5.14%)
Market Cap
$5.12B
Shares
66.21M
Volume · Oct 9 468.3K Avg daily vol (3M) 891.49K

Analyst Estimates

Compare analyst forecasts for Oruka Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-08 09:43 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.9
-2.36632
-1.83
—
-2.36632
-2.03882
-2.36632
-2.03882
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
8
1
1
0
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.09
-2.86212
-2.19104
—
-2.86212
-2.49214
-2.86212
-2.49214
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
6
1
3
0
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.79
-0.61832
-0.41
—
-0.61832
-0.50668
-0.61832
-0.50668
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
7
1
1
0
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.86
-0.6627
-0.4
—
-0.6627
-0.53263
-0.6627
-0.53263
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
8
1
1
0
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 907654 CUSIP 687604108 13F (30d) 7 filings 7 filers Visit website Investor relations